A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10-60 Years Following Essen and Zagreb Vaccination Procedures.
Xiaohong WuJia LiLei ZhouJianmin ChenZhongqiang JinQingwei MengJing ChaiHongxia GaoYunpeng WangDanhua ZhaoHeng WuJieran YuNan ChenYanan WangYuan LinPeifang HuangYuhua LiYuhui ZhangPublished in: Vaccines (2023)
The investigated vaccine is safe, its immunogenicity is non-inferior to that of the control vaccine, and the efficacy of the Zagreb procedure is superior to that of the Essen procedure 7 days after the first dose.